“They are going to take advantage of the learning curve,” said Vijay Samant, a former Merck executive. Samantha said that vaccine manufacturers have months to meet supply bottlenecks and anticipate manufacturing to accelerate in the coming months – a boon for the Biden administration.
Samantha said, “They might get a lot of credit because suddenly vaccine supplements are going to be available and it’s like, ‘Oh, well, we’ve done this.” “Let me tell you, how it works. They are on the right end of the curve.”
Connecticut Village. Ned Lamont, a Democrat, said in a similarly optimistic tone on Thursday that vaccine supplies would increase rapidly in February and March. Governor’s spokesman Max Riss said the governor renegotiated with Pfizer, during which the company reiterated plans for a huge increase in production in February. Under the Defense Production Act, the ramp-up is already taking place before the Biden administration takes any step.
In an interview on ABC’s “Good Morning America”, Biden’s chief medical adviser expressed confidence in the president’s one-time far-reaching goal to vaccinate 100 million people in his first 100 days.
“I am fairly confident that this is not only going to happen, but maybe even better,” Fauci said, noting the contractual agreements that were in place. “The amount that is going to come, we will be able to meet that goal.”
Nevertheless, questions remain about where the current US vaccine supply is. The new administration has deferred strong federal plans to introduce large numbers of vaccination sites and to deploy mobile units for hard-hit communities, as well as citing the lack of supply of some state vaccination sites at existing vaccination sites Canceling appointments.
Biden’s team has said that it is getting somewhat blind when it comes to supplying the vaccine and how it is allocated across the country. A source close to the transition told CNN that the Biden team had been denied access to the critical resources needed to properly complete supplies and handle the rollout before Biden took over.
“The lack or hindrance of cooperation funding from the Trump administration has been a hindrance,” White House Kovid-19 coordinator Jeff Zisters told reporters. “So we don’t have the visibility that we would expect in supply and allocation.”
To be sure, there is still not nearly enough vaccine available – in the US or worldwide – and the US has stumbled into acquiring weapons quickly. But the Biden administration also appears to be trying to manage expectations, shamelessly outplaying the Trump administration and figuring out what concrete steps can be taken to improve vaccine manufacturing and distribution.
Except for work agencies looking for opportunities to use the Defense Production Act, the Biden administration has not clearly articulated what it is doing to improve vaccine supply.
Biden “is fully committed to implementing the Defense Production Act to obtain the materials and supplies needed to obtain vaccines to Americans around the country and to its goal of achieving 100 million shots in the arms of the first Americans” Is. 100 days, “White House press secretary Jane Saki said Thursday.
The White House did not explain how they would communicate or work with the states, but CNN spokesman Kevin Munoz reiterated in a statement that they would “listen to the unique needs of the states and provide us with the federal government’s resources and guidance to ensure Will suit. ” Vaccines are thrust into the arms of Americans as soon as possible and safely. “
White House officials said they have asked the Department of Health and Human Services to look for all possible sources of a type of syringe that could help remove more doses of the Pfizer vaccine from each vial. On Thursday, Biden said he would sign an executive order to use the Defense Production Act to accelerate the creation of everything federal agencies and private industries “do to protect, test and vaccinate and take care of our people Are required for. ”
A former administration official told CNN that the Trump administration had already implemented the Defense Production Act to assist each of the six vaccine manufacturers, as well as needle and syringe contracts.
“We are working to focus on all components of the supply chain and focus on manufacturing,” White House Kovid supply coordinator Tim Manning told reporters. The Defense Production Act is a powerful tool – a powerful set of tools – and There are several ways we can help ensure that there is an adequate and growing supply of vaccines. “
Vaccine expert Samanta said it would be better to focus on the availability of raw materials like lipids rather than administration specific syringes.
“It’s like the most ridiculous thing to chase,” Samant said of hastening syringe production, saying that such a move could, at best, improve vaccine supply by up to 5% .
For the Biden team, it is important to understand how much supplies are available in the coming months and how much may actually be available. States have stated that they need clear and consistent guidance on vaccine supply so that they can streamline their immunization programs.
“We will work to provide estimates on supply. We hear more and more from governors and local leaders that they have no idea what supplies are coming and cannot plan. We are going to get our arms next.” Will do completely in a few days. What’s happening, make sure we’re communicating with states and localities, so they can prepare effectively, “Zaders said.
According to a health official involved in the vaccine delivery process, hospitals receiving the modern vaccine complained of being completely in the dark when they were receiving it and how much they were getting, and in some cases, surprising them Shipment was sent. Modern declined to comment.
All these problems are now being squared off in the lap of the new administration.
Some state officials said they are already worried about what the administration’s plan would be to allocate vaccines to states and communicate with them.
Under the previous administration, the then Vice President Mike Pence and members of the Kovid Task Force interacted regularly with the country’s governors during most of the epidemic. Although some governors found the call largely useless, they could at least rely on briefings to hear from high-grade medical experts and ask administration questions.
The day after Biden took office, state officials told CNN that there is still a lot of confusion about how states are working and communicating with the Biden administration as the epidemic continues to grow and vaccine distribution is far behind. .
According to a Republican state official, the National Governors Association has come out with some of its governors to work with the Bovid administration. However, not all governors are members of the organization and it is unclear how the administration plans to work with people outside the association.
A Democratic state official said he too had no regular dialogue with the new administration.
White House immunization coordinator Drs. Bechar Chaure is in touch with some governors, but has not stated how the administration will deal with the vaccine allocation.
Biden said Thursday that each state would be assigned a liaison with the Federal Emergency Management Agency.
But in a news briefing on Thursday, Psaki could not provide any more details on how it would improve communication with the states.
The new Kovid team, she said, “will engage with governors, Democrats and Republicans, mayors, local elected officials to gain a better understanding of what’s happening on the ground.”